260 related articles for article (PubMed ID: 11024153)
1. Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis.
Ruf IK; Rhyne PW; Yang C; Cleveland JL; Sample JT
J Virol; 2000 Nov; 74(21):10223-8. PubMed ID: 11024153
[TBL] [Abstract][Full Text] [Related]
2. Role of Epstein-Barr virus in Burkitt's lymphoma.
Takada K
Curr Top Microbiol Immunol; 2001; 258():141-51. PubMed ID: 11443859
[TBL] [Abstract][Full Text] [Related]
3. Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma.
Ruf IK; Rhyne PW; Yang H; Borza CM; Hutt-Fletcher LM; Cleveland JL; Sample JT
Mol Cell Biol; 1999 Mar; 19(3):1651-60. PubMed ID: 10022853
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.
Komano J; Sugiura M; Takada K
J Virol; 1998 Nov; 72(11):9150-6. PubMed ID: 9765461
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata.
Komano J; Maruo S; Kurozumi K; Oda T; Takada K
J Virol; 1999 Dec; 73(12):9827-31. PubMed ID: 10559294
[TBL] [Abstract][Full Text] [Related]
6. Role of bcl-2 in Epstein-Barr virus-induced malignant conversion of Burkitt's lymphoma cell line Akata.
Komano J; Takada K
J Virol; 2001 Feb; 75(3):1561-4. PubMed ID: 11152530
[TBL] [Abstract][Full Text] [Related]
7. Replacement of the Epstein-Barr virus plasmid with the EBER plasmid in Burkitt's lymphoma cells.
Maruo S; Nanbo A; Takada K
J Virol; 2001 Oct; 75(20):9977-82. PubMed ID: 11559830
[TBL] [Abstract][Full Text] [Related]
8. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma.
Nanbo A; Inoue K; Adachi-Takasawa K; Takada K
EMBO J; 2002 Mar; 21(5):954-65. PubMed ID: 11867523
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction.
Kitagawa N; Goto M; Kurozumi K; Maruo S; Fukayama M; Naoe T; Yasukawa M; Hino K; Suzuki T; Todo S; Takada K
EMBO J; 2000 Dec; 19(24):6742-50. PubMed ID: 11118209
[TBL] [Abstract][Full Text] [Related]
11. The role of Epstein-Barr virus-encoded small RNAs (EBERs) in oncogenesis.
Nanbo A; Takada K
Rev Med Virol; 2002; 12(5):321-6. PubMed ID: 12211044
[TBL] [Abstract][Full Text] [Related]
12. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV.
Shimizu N; Tanabe-Tochikura A; Kuroiwa Y; Takada K
J Virol; 1994 Sep; 68(9):6069-73. PubMed ID: 8057484
[TBL] [Abstract][Full Text] [Related]
13. EBV interferes with the sensitivity of Burkitt lymphoma Akata cells to etoposide.
Lima RT; Seca H; Soares P; Nascimento MS; Vasconcelos MH
J Cell Biochem; 2011 Jan; 112(1):200-10. PubMed ID: 21069730
[TBL] [Abstract][Full Text] [Related]
14. The role of EBERs in oncogenesis.
Takada K; Nanbo A
Semin Cancer Biol; 2001 Dec; 11(6):461-7. PubMed ID: 11669608
[TBL] [Abstract][Full Text] [Related]
15. Association between Epstein-Barr virus and Burkitt's lymphoma in Taiwan.
Chao TY; Wang TY; Lee WH
Cancer; 1997 Jul; 80(1):121-8. PubMed ID: 9210717
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain.
Trivedi P; Spinsanti P; Cuomo L; Volpe M; Takada K; Frati L; Faggioni A
J Virol; 2001 May; 75(10):4929-35. PubMed ID: 11312367
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic role of Epstein-Barr virus in human cancer.
Takada K; Shimizu N; Tanabe-Tochikura A; Kuroiwa Y
Intervirology; 1995; 38(3-4):214-20. PubMed ID: 8682619
[TBL] [Abstract][Full Text] [Related]
18. Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus.
Sheng W; Decaussin G; Ligout A; Takada K; Ooka T
J Virol; 2003 Mar; 77(6):3859-65. PubMed ID: 12610162
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
20. Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma line.
Cuomo L; Ramquist T; Trivedi P; Wang F; Klein G; Masucci MG
Int J Cancer; 1992 Jul; 51(6):949-55. PubMed ID: 1322379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
